Jerry S. Lanchbury

2018

In 2018, Jerry S. Lanchbury earned a total compensation of $2.4M as Chief Scientific Officer at Myriad Genetics, a 31% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$244,422
Salary$493,782
Stock Awards$1,628,500
Other$10,972
Total$2,377,676

Lanchbury received $1.6M in stock awards, accounting for 68% of the total pay in 2018.

Lanchbury also received $244.4K in non-equity incentive plan, $493.8K in salary and $11K in other compensation.

Rankings

In 2018, Jerry S. Lanchbury's compensation ranked 4,887th out of 14,244 executives tracked by ExecPay. In other words, Lanchbury earned more than 65.7% of executives.

ClassificationRankingPercentile
All
4,887
out of 14,244
66th
Division
Manufacturing
1,833
out of 5,758
68th
Major group
Chemicals And Allied Products
669
out of 2,119
68th
Industry group
Drugs
561
out of 1,808
69th
Industry
In Vitro and In Vivo Diagnostic Substances
13
out of 72
82nd
Source: SEC filing on October 10, 2018.

Lanchbury's colleagues

We found four more compensation records of executives who worked with Jerry S. Lanchbury at Myriad Genetics in 2018.

2018

Mark Capone

Myriad Genetics

Chief Executive Officer

2018

Alexander Ford

Myriad Genetics

President, Myriad Womens Health, Inc

2018

R Riggsbee

Myriad Genetics

Chief Financial Officer

2018

Richard Marsh

Myriad Genetics

General Counsel

News

You may also like